Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zivanovic

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1991
The enzyme-inhibitor approach to cell-selective labelling--II. In vivo studies with pIBS in small animals and manJ Singh, P Wyeth, D M Ackery, et al.
European Journal of Nuclear Medicine|January 1, 1989
Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidineG M Blake, V J Lewington, M A Zivanovic, et al.
European Journal of Nuclear Medicine|October 1, 1979
The stability and distribution of Tc-HIDA in vivo and in vitroM A Zivanovic, D M Taylor, V R McCready, et al.
European Journal of Nuclear Medicine|January 1, 1986
Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostateG M Blake, M A Zivanovic, A J McEwan, et al.
European Journal of Gynaecological Oncology|May 17, 2018
Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, SerbiaV Jovanovic, A Mitrovic Jovanovic, A Zivanovic, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytomaV J Lewington, M A Zivanovic, M Tristam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefitM Tristam, A S Alaamer, J S Fleming, et al.
Nuclear Medicine Communications|July 22, 2004
Guidelines for the measurement of glomerular filtration rate using plasma samplingJohn S Fleming, Maureen A Zivanovic, Glen M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1991
The enzyme-inhibitor approach to cell-selective labelling--II. In vivo studies with pIBS in small animals and manJ Singh, P Wyeth, D M Ackery, et al.
European Journal of Nuclear Medicine|January 1, 1989
Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidineG M Blake, V J Lewington, M A Zivanovic, et al.
European Journal of Nuclear Medicine|October 1, 1979
The stability and distribution of Tc-HIDA in vivo and in vitroM A Zivanovic, D M Taylor, V R McCready, et al.
European Journal of Nuclear Medicine|January 1, 1986
Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostateG M Blake, M A Zivanovic, A J McEwan, et al.
European Journal of Gynaecological Oncology|May 17, 2018
Knowledge about cervical cancer, Pap test, and barriers to women's participation in screening in Belgrade, SerbiaV Jovanovic, A Mitrovic Jovanovic, A Zivanovic, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)|October 1, 1991
Radiolabelled metaiodobenzylguanidine targeted radiotherapy for malignant phaeochromocytomaV J Lewington, M A Zivanovic, M Tristam, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy: risk versus benefitM Tristam, A S Alaamer, J S Fleming, et al.
Nuclear Medicine Communications|July 22, 2004
Guidelines for the measurement of glomerular filtration rate using plasma samplingJohn S Fleming, Maureen A Zivanovic, Glen M Blake, et al.
European Journal of Nuclear Medicine|January 1, 1988
Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytomaG M Blake, V J Lewington, J S Fleming, et al.
European Journal of Nuclear Medicine|January 1, 1987
89Sr radionuclide therapy: dosimetry and haematological toxicity in two patients with metastasising prostatic carcinomaG M Blake, M A Zivanovic, A J McEwan, et al.
Pageof 3